Anning Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- Peroxisome Proliferator-Activated Receptors 9
- RNA modifications and cancer 6
- Genetics 16
- Genetic and phenotypic traits in livestock 10
- Co-authors
- Yaosheng Chen (11 shared papers)Delin Mo (11 shared papers)Yuna Niu (7 shared papers)Zuyong He (6 shared papers)Xiao Zhao (8 shared papers)Limei Qin (6 shared papers)Shuqi Xiao (7 shared papers)Qiwei Wang (4 shared papers)
- Journals
- DNA and Cell Biology (4 papers)Gene (3 papers)PLoS ONE (3 papers)Scientific Reports (2 papers)Frontiers in Immunology (2 papers)
- Partner nations
- ChinaUnited StatesSpain
In The Last Decade
Anning Li
90 papers receiving 2.0k citations
Hit Papers
Peers
Comparison fields: 5 of 134
- Cancer Research 401
- Biomaterials 268
- Animal Science and Zoology 177
- Immunology 255
- Molecular Biology 763
Countries citing papers authored by Anning Li
This map shows the geographic impact of Anning Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anning Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anning Li more than expected).
Fields of papers citing papers by Anning Li
This network shows the impact of papers produced by Anning Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anning Li. The network helps show where Anning Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Anning Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 92 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection Hit paper breakdown → | 2021 | 240 |
| 2 | 2010 | 179 | |
| 3 | 2011 | 143 | |
| 4 | 2010 | 118 | |
| 5 | Application of Chitosan-Based Hydrogel in Promoting Wound Healing: A Review Hit paper breakdown → | 2024 | 64 |
| 6 | 2019 | 61 | |
| 7 | 2011 | 60 | |
| 8 | 2021 | 57 | |
| 9 | 2021 | 55 | |
| 10 | 2021 | 49 | |
| 11 | 2022 | 40 | |
| 12 | 2016 | 38 | |
| 13 | 2013 | 37 | |
| 14 | 2020 | 33 | |
| 15 | 2019 | 33 | |
| 16 | 2018 | 32 | |
| 17 | 2016 | 28 | |
| 18 | 2012 | 27 | |
| 19 | 2016 | 26 | |
| 20 | 2020 | 26 |
About Anning Li
Anning Li is a scholar working on Molecular Biology, Genetics, Immunology, Cancer Research and Biomedical Engineering, having authored 92 papers that have together received 2.0k indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (10 papers), Genetic and phenotypic traits in livestock (10 papers), Peroxisome Proliferator-Activated Receptors (9 papers), Cancer-related molecular mechanisms research (8 papers), RNA modifications and cancer (6 papers), Immunotherapy and Immune Responses (6 papers), Immune cells in cancer (6 papers) and Schizophrenia research and treatment (6 papers). The work is most often cited by research in Cancer Research (401 citations), Biomaterials (268 citations), Animal Science and Zoology (177 citations), Immunology (255 citations) and Molecular Biology (763 citations). Anning Li has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Yaosheng Chen, Delin Mo, Yuna Niu, Zuyong He, Xiao Zhao, Limei Qin, Shuqi Xiao, Qiwei Wang, Linsen Zan and Jing Zhang. Their work appears in journals such as DNA and Cell Biology, Gene, PLoS ONE, Scientific Reports and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.